A comparison of in vitro studies between cobalt(III) and copper(II) complexes with thiosemicarbazone ligands to treat triple negative breast cancer
Duaa R. Alajroush, Chloe B. Smith, Brittney F. Anderson, Ifeoluwa T. Oyeyemi, Stephen J. Beebe, Alvin A. Holder
Topics & Concepts
Triple-negative breast cancerCobaltSemicarbazoneCopperIn vitroChemistryBreast cancerCancer researchCancerStereochemistryInternal medicineMedicineBiochemistryInorganic chemistryOrganic chemistryMetal complexes synthesis and propertiesSynthesis and biological activityNanoparticle-Based Drug Delivery